You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Quantitative IgG

Showing 1 - 25 of 4,206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals

Recruiting
  • Hematologic Neoplasms
  • COVID-19 Vaccines
  • S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests
  • +2 more
  • Vilnius, Lithuania
    Vilnius University Hospital Santaros Klinikos
Dec 27, 2021

Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Completed
  • SARS-CoV-2 Vaccination
  • Liver Transplantation
  • Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
  • Roma, Italy
    Policlinico Tor Vergata
Aug 3, 2022

COVID-19 Trial in Benoni, Durban (drug, diagnostic test, other)

Recruiting
  • COVID-19
  • Covidir injections
  • +8 more
  • Benoni, South Africa
  • +1 more
May 9, 2022

Autoimmune Mechanisms in Fibromyalgia

Completed
  • Fibromyalgia
  • Questionnaires, quantitative sensory testing, blood sampling, skin biopsies, functional magnetic resonance imaging, magnetic resonance spectroscopy
  • Stockholm, Sweden
    Karolinska Insitutet
Apr 3, 2023

Humoral Immunity Trial in Gomel (Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by

Enrolling by invitation
  • Humoral Immunity
  • Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
  • Gomel, Belarus
    Gomel State Medical University
Jan 30, 2023

Lymphoma Trial in Seattle (biological, other, procedure)

Not yet recruiting
  • Lymphoma
  • Immune Globulin Infusion (Human), 10% Solution
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2023

Healthcare Worker Recipients

Completed
  • Covid19
  • Vaccine Reaction
  • COVID-19 vaccine
  • Pasadena, California
    Huntington Hospital
May 2, 2022

COVID-19 IgG Antibodies in Maternal and Cord Blood Samples

Withdrawn
  • Covid19
  • +2 more
    • (no location specified)
    Apr 19, 2022

    Immunogenicity of BNT162b2 Covid-19 Vaccine in Elderly People

    Completed
    • Immunogenicity, Vaccine
      • Thessaloníki, Thessaloniki, Greece
        G. Gennimatas General Hospital
      Aug 3, 2022

      Covid19 Trial in Netherlands (Vaccination once with Janssen vaccine (only priming), Vaccination with Janssen vaccine followed

      Recruiting
      • Covid19
      • Vaccination once with Janssen vaccine (only priming)
      • +3 more
      • Amsterdam, Netherlands
      • +3 more
      Jun 26, 2021

      Myasthenia Gravis Trial in Canada, United States (RVT-1401, Placebo)

      Completed
      • Myasthenia Gravis
      • Mobile, Alabama
      • +19 more
      Oct 6, 2021

      Vaccine Adverse Reaction, COVID-19, Vaccine Reaction Trial in San Nicolás De Los Garza (COVID-19 Vaccines)

      Recruiting
      • Vaccine Adverse Reaction
      • +2 more
      • COVID-19 Vaccines
      • San Nicolás De Los Garza, Mexico
        Hospital Clinica Nova de Monterrey
      Mar 25, 2022

      Relapsing Multiple Sclerosis (RMS) Trial in United States (Ofatumumab, mRNA COVID-19 vaccine, interferon or glatiramer acetate)

      Recruiting
      • Relapsing Multiple Sclerosis (RMS)
      • Phoenix, Arizona
      • +3 more
      Jul 20, 2022

      Evaluation Study of Dengue RDTs

      Recruiting
      • Dengue Fever
      • Diagnostic test: 5 different Rapid diagnostic test and Reference tests
      • Karachi, Sindh, Pakistan
        Aga Khan University
      Oct 12, 2022

      Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2

      Recruiting
      • Influenza
      • COVID-19
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 13, 2022

        Covid-19 Vaccination Trial (Direct boost mRNA, Direct boost adeno, Post-poned boost mRNA)

        Not yet recruiting
        • Covid-19 Vaccination
        • Direct boost mRNA
        • +3 more
        • (no location specified)
        Jul 21, 2022

        Covid19 Trial in Giza (Astrazenica vaccine)

        Recruiting
        • Covid19
        • Astrazenica vaccine
        • Giza, Egypt
          Samia El-Shishtawy
        Aug 29, 2021

        IgG Subclasses and on Immunity of Secondary Immunodeficiency

        Completed
        • Secondary Immune Deficiency
        • Chalon-sur-Saône, France
        • +5 more
        Feb 28, 2022

        Plasma From People Who Recovered From or Were Vaccinated to

        Enrolling by invitation
        • Communicable Diseases
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Sep 27, 2022

          Systemic and Nasal Mucosal Immunity After Influenza Vaccination

          Active, not recruiting
          • Influenza Immunity
            • Bethesda, Maryland
              National Institute of Allergy and Infectious Diseases (NIAID)
            Jul 6, 2022

            Study of the Effectiveness of The COVID-19 Vaccine

            Completed
            • COVID-19
            • COVID-19 Antibody
            • Sukoharjo, Central Java, Indonesia
              Universitas Sebelas Maret Hospital
            Mar 9, 2023

            Malaria, Malaria,Falciparum, Protozoan Infections Trial in Sheffield (Matrix M with RH5.1)

            Recruiting
            • Malaria
            • +5 more
            • Matrix M with RH5.1
            • Sheffield, United Kingdom
              Sheffield Teaching Hospitals, Royal Hallamshire Hospital
            Nov 14, 2023

            COVID-19, SARS-CoV-2 Trial in London (COVI-VAC)

            Completed
            • COVID-19
            • SARS-CoV-2
            • COVI-VAC
            • London, United Kingdom
              HMR
            Jan 11, 2023

            Burden of Hepatitis D Virus Infection in China Through

            Not yet recruiting
            • Hepatitis D
            • +3 more
            • HDV-Ab (IgG), HDV-RNA, RNA genotype
            • (no location specified)
            Nov 1, 2022

            Following SARS-CoV-2 (Covid-19) Vaccinations

            Recruiting
            • Covid-19
            • Subjects Vaccinated Against Covid-19
            • Change in SARS-CoV-2 Antibody Levels
            • Southlake, Texas
              Southlake Diagnostics, Inc.
            Aug 26, 2022